Documentos relacionados

1. A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease.
2. Fenoterol: a beta2-adrenergic agonist for use in asthma. Pharmacology, pharmacokinetics, clinical efficacy and adverse effects.
3. [Role of Bronchodual in the long-term treatment of asthma in children].
4. In vitro synthesis and characterisation of three fenoterol sulfoconjugates detected in fenoterol post-administration urine samples.
5. Comparison efficacy of randomized nebulized magnesium sulfate and ipratropium bromide/fenoterol in children with moderate to severe asthma exacerbation.
6. [Comparison of acute bronchiolytic effect of inhaling solutions of berodual vs salgim using a nebulizer in patients with chronic obstructive bronchitis and bronchial asthma].
7. Fenoterol: a review of its pharmacological properties and therapeutic efficacy in asthma.
8. [Ultrasonic spray protection against bronchospasm. Comparison of fenoterol and a combination of salbutamol and ipratropium bromide].
9. [Evaluation of the therapeutic effectiveness of orally administered fenoterol in asthmatic children].
10. Comparison of a single dose of aerosol salbutamol and fenoterol/ipratropium on bronchial asthmatic patients.